Valuation: Sanofi

Market Cap 89.35B 99.84B 82.62B 74.83B 140B 9,515B 142B 993B 393B 4,972B 375B 367B 15,723B P/E 2026 *
11.9x
P/E 2027 * 10.3x
Enterprise Value 101B 113B 93.1B 84.32B 158B 10,723B 160B 1,119B 443B 5,603B 422B 413B 17,718B EV / Sales 2026 *
2.12x
EV / Sales 2027 * 1.92x
Free-Float
88.34%
Yield 2026 *
5.72%
Yield 2027 * 6.05%
1 day+0.62%
1 week+3.67%
Current month+2.67%
1 month+3.89%
3 months-1.91%
6 months-6.87%
Current year-9.84%
1 week 71.39
Extreme 71.39
75.31
1 month 69.75
Extreme 69.75
75.31
Current year 69.75
Extreme 69.75
84.97
1 year 69.75
Extreme 69.75
90.79
3 years 69.75
Extreme 69.75
110.88
5 years 69.75
Extreme 69.75
110.88
10 years 62.88
Extreme 62.88
110.88
Manager TitleAgeSince
Chief Executive Officer 65 2026-04-30
Director of Finance/CFO 64 2024-03-31
Chief Tech/Sci/R&D Officer - 2026-08-31
Director TitleAgeSince
Director/Board Member 61 2019-04-29
Director/Board Member 56 2020-04-27
Director/Board Member 65 2020-04-27
Date Insider Type Main position Quantity % Market Cap. Importance
8/20/26 Buy

Chief Executive Officer

1,506 0.0001%
8/20/26 Buy

Head of Human Resources

54 0.0000%
8/20/26 Buy

Executive/Senior Manager

840 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.62%+3.67%-16.00%-26.17% 99.44B
+0.45%+1.76%+54.96%+118.11% 1,135B
+0.94%+4.20%+39.86%+75.69% 635B
+0.39%+0.46%+25.77%+97.40% 505B
+1.43%+4.56%+46.20%+66.91% 378B
-3.21%-3.66%+60.72%+35.68% 358B
-0.41%+2.23%+22.48%+48.54% 295B
+0.23%+3.28%+2.57%+21.89% 266B
+1.22%+2.81%+52.40%+63.37% 237B
+1.70%+1.60%+31.21%+102.44% 193B
Average +0.29%+1.74%+32.02%+60.39% 410.31B
Weighted average by Cap. +0.19%+1.66%+40.01%+78.43%

Financials

2026 *2027 *
Net sales 47.56B 53.15B 43.98B 39.83B 74.47B 5,065B 75.79B 529B 209B 2,647B 199B 195B 8,370B 50.66B 56.61B 46.84B 42.42B 79.32B 5,395B 80.72B 563B 223B 2,819B 212B 208B 8,914B
Net income 7.67B 8.57B 7.09B 6.42B 12.01B 817B 12.22B 85.27B 33.75B 427B 32.16B 31.48B 1,350B 9.07B 10.14B 8.39B 7.6B 14.21B 966B 14.46B 101B 39.93B 505B 38.05B 37.23B 1,597B
Net Debt 11.34B 12.67B 10.48B 9.49B 17.75B 1,207B 18.06B 126B 49.89B 631B 47.54B 46.53B 1,995B 8B 8.94B 7.4B 6.7B 12.53B 852B 12.75B 88.99B 35.22B 445B 33.56B 32.85B 1,408B
Projected Income Statement - Annual - Sanofi
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Date Price Change Volume
26-10-26 €74.58 +0.62% 1,802,573
26-10-23 €74.12 -1.11% 1,742,949
26-10-22 €74.95 +1.88% 2,002,753
26-10-21 €73.57 -0.01% 1,313,585
26-10-20 €73.58 +3.62% 1,926,589
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Sanofi
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
74.58EUR
Average target price
93.35EUR
Spread / Average Target
+25.17%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Sanofi